Know Cancer

or
forgot password

Platelet-Rich and Concentrated Platelet Poor Plasma to Reduce Air Leak Post Lobectomy: A Randomized Controlled Trial


N/A
18 Years
N/A
Not Enrolling
Both
Lung Cancer

Thank you

Trial Information

Platelet-Rich and Concentrated Platelet Poor Plasma to Reduce Air Leak Post Lobectomy: A Randomized Controlled Trial


Inclusion Criteria:



- Patients requiring a lobectomy

Exclusion Criteria:

- Pneumonectomy

- Sleeve lobectomy

- Determination of unresectability (prior to the initiation of lobectomy)

- Wedge resection alone

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Caregiver, Investigator), Primary Purpose: Treatment

Outcome Measure:

Duration of postoperative air leak

Outcome Time Frame:

Every 4 hours of postop hospital stay, between 4-6 weeks postop

Safety Issue:

No

Principal Investigator

Richard Inculet, MD, FRCSC, FACS

Investigator Role:

Principal Investigator

Investigator Affiliation:

University of Western Ontario, Canada

Authority:

Canada: Ethics Review Committee

Study ID:

BBI-004

NCT ID:

NCT00665912

Start Date:

January 2008

Completion Date:

November 2010

Related Keywords:

  • Lung Cancer
  • Lung Neoplasms

Name

Location